Brain-penetrating peptides Peptide shuttles represent a significant advancement in targeted drug delivery, particularly for challenges posed by the blood-brain barrier (BBB)作者:X Peng·2023·被引用次数:11—We developed a combinatorial approach to identifypeptides that can shuttle and transport across both barriers.. These specially designed peptides act as molecular couriers, facilitating the passage of therapeutic compounds that would otherwise struggle to cross this formidable biological defense. As research intensifies, peptide shuttles are emerging as a crucial tool for treating neurological disorders and other conditions affecting the central nervous system (CNS).
The primary function of peptide shuttles is to overcome the BBB, a highly selective barrier that protects the brain from harmful substances.作者:X Peng·2019·被引用次数:11—We describe a combinatorial approach to identifypeptide shuttles that successfully traverse the multiple barriers to systemic drug deliveryto the brain. Traditional drug delivery methods often fail to achieve therapeutic concentrations within the brain due to the BBB's restrictive nature. Peptide shuttles, however, are engineered to bind to specific receptors or utilize natural transport mechanisms on the BBB, effectively ushering attached or conjugated therapeutic agents into the brain tissue.作者:P Arranz-Gibert·2018·被引用次数:16—BBB shuttles—short peptides able to cross the BBB—are being developed to help therapeutics to cross this barrier. BBB shuttles can be discovered ... This capability is critical for developing effective treatments for a wide range of brain diseases.
The effectiveness of peptide shuttles stems from their ability to leverage various biological transport pathwaysNew Trends in Brain Shuttle Peptides. Some shuttles are designed to bind to receptors that are actively involved in nutrient or protein transport across the BBB, a process known as receptor-mediated transcytosis.Design of peptide shuttles importing Cu into cells and able to ... Others may exploit paracellular pathways or utilize specific transporter proteins.作者:B Oller-Salvia·2016·被引用次数:538—Peptide shuttles have received growing attention because of theirlower cost, reduced immunogenicity, and higher chemical versatilitythan traditional Trojan ... This targeted approach minimizes off-target effects and enhances the efficiency of drug delivery作者:AS Lane·1997·被引用次数:308—In addition to being able to control the position of the macrocycle inpeptide-based molecularshuttles, the sensitivity of the intercomponent hydrogen bond ....
Compared to conventional drug delivery systems, peptide shuttles offer several distinct advantages. Their relatively small size and peptide nature generally lead to reduced immunogenicity, meaning they are less likely to provoke an adverse immune response. Furthermore, their chemical versatility allows for a wide range of modifications, enabling researchers to fine-tune their binding affinity, targeting specificity, and payload capacity. This adaptability also translates to potentially lower costs in large-scale production and a higher degree of chemical customization than some traditional methodsBrain-Penetrating Peptide Shuttles Across the Blood- ....
The field of peptide shuttles has seen substantial progress over the past decade, with ongoing research focusing on identifying novel sequences and optimizing existing designs. Early work explored various peptide families, and more recent trends highlight the development of "next-generation" shuttles with improved transport efficiency and broader applicabilityPeptide Shuttles for Blood–Brain Barrier Drug Delivery. Researchers are continually refining strategies to enhance their transport capabilities, aiming to deliver not only small molecules but also larger therapeutics like proteins and nanocarriers across the BBB.
Future developments are expected to focus on creating more sophisticated peptide shuttles with multi-functional capabilities. This could include shuttles that can simultaneously target multiple receptors, release their payload in response to specific cellular signals within the brain, or even possess diagnostic imaging properties(PDF) Peptide Shuttles for Blood–Brain Barrier Drug Delivery. The goal is to move beyond simple transport and enable highly precise, responsive, and integrated therapeutic interventions for complex neurological conditions.
The most prominent application of peptide shuttles is in the delivery of therapeutics for CNS diseases, including neurodegenerative disorders like Alzheimer's and Parkinson's, as well as brain tumors and stroke. By enabling drugs to reach therapeutic concentrations in the brain, these shuttles hold the promise of significantly improving treatment outcomes for conditions that have historically been difficult to manage.
Beyond drug delivery, peptide shuttles are also being explored for other applications. For instance, research is investigating their use in delivering specific ions, such as copper (Cu), into cells, which could have implications for understanding and treating diseases involving metal dysregulation. The development of methods for identifying new BBB peptide shuttles is also a critical area of research, paving the way for a broader arsenal of tools to combat brain-related ailments2025年2月3日—We highlight the most utilizedpeptidesand describe trends in strategies to develop newshuttlesand enhance their transport efficiency.. The continued exploration of these diverse applications underscores the broad potential of peptide shuttle technologyNew Trends in Brain Shuttle Peptides.
Join the newsletter to receive news, updates, new products and freebies in your inbox.